We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




LAMP Assay Validated for Visceral Leishmaniasis

By LabMedica International staff writers
Posted on 03 Dec 2018
Visceral leishmaniasis (VL) is one of the most neglected infectious diseases with an annual incidence of 50,000 to 90,000 new cases worldwide. More...
Cases of VL are characterized by irregular bouts of fever, weight loss, hepatosplenomegaly, hypergammaglobulinemia, pancytopenia and anaemia.

Diagnosis of VL is based on combining the clinical examination involving a history of fever of more than two weeks with splenomegaly and hepatomegaly along with positive parasitological or serological tests. Demonstration of amastigotes by microscopy is invasive, risky and technically demanding with the limitation of low sensitivity.

A team of scientists working with the Safdarjung Hospital Campus (Pune, India) included in a study a total of 267 eligible participants, which comprised of 179 VL cases and 88 controls. VL suspects having fever for more than two weeks and coming from VL endemic area were tested using the rapid diagnostic test, the rK39 strip test and/or microscopic examination of Giemsa stained splenic or bone marrow aspirates for the presence of Leishmania donovani amastigotes.

The team developed a simplified Loop Mediated Isothermal Amplification (LAMP) assay based on direct blood lysis, DBL-LAMP, was developed and verified for its diagnostic accuracy. They also performed a closed tube LAMP assay previously described. At the end of reaction, the tubes were allowed to cool down to room temperature and a brief spin was given to allow mixing of SYBR Green I with the amplified product. The positives instantaneously turned green while the negatives remained orange.

The scientists reported that the sensitivity and specificity of the LAMP assay were 98.3% and 96.6% respectively. ROC curve analysis depicted no significant difference between area under curve (AUCROC) for LAMP assay and rK39 RDT, indicative of LAMP as an excellent diagnostic test. DBL-LAMP assay, performed on 67 VL and 100 control samples, yielded a sensitivity of 93.1% and specificity of 100%. The DBL-LAMP assay for VL diagnosis was easier to perform along with reduction in cost and turnaround time, putting it one step forward towards field application. The overall time for performing LAMP assay was reduced to half (1.25 hours) when direct blood lysis was used rather than column extracted DNA which surpassed the requirement of DNA isolation by the use of crude direct lysed supernatant in place of DNA.

The authors concluded that the validated closed tube LAMP for diagnosis of VL will provide impetus to the ongoing VL elimination programme in the Indian subcontinent. The assay based on direct blood lysis promotes its scope for application in field settings by further reducing time and cost. The study was published on November 15, 2018, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Safdarjung Hospital Campus


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Thyroid Test
Anti-Thyroid EIA Test
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.